Clinical research of celiprolol, fexofenadine, atenolol cocktail-microdose to validate the utility of microdose study on the drug transporter SNP's
Not Applicable
- Conditions
- healthy male
- Registration Number
- JPRN-UMIN000002714
- Lead Sponsor
- APDD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
the investigors must ensure that all subjects being considerd meet the following exclusion criteria or conditions: 1)history of allergy to any drugs 2)medical attention within 2 months prior to participation 3)donation of 200mL or more of blood within 4 weeks prior to participation, or donation of component blood within 2 weeks prior to participation 4)donation of 400mL or more of blood within 12 weeks prior to participation 5)recent (past 4 months) participation in other clinical trial for investigational new chemical entity 6)history of drug abuse 7)alcohol abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PK profiles of celiprolol, fexofenadine and atenolol
- Secondary Outcome Measures
Name Time Method